Merck & Co.
1891
FOUNDED
PUBLIC
STATUS
65K-70K
EMPLOYEES
MRK
STOCK SYMBOL
56
INVESTMENTS
$89.65
SHARE PRICE
(As of Wednesday Closing)
Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
NYS
Primary Office
- 2000 Galloping Hill Road
- Kenilworth, NJ 07033
- United States
+1 (908) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Merck & Co.’s full profile, request a free trial.
Merck & Co. Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $72.05 - $92.64 | $228B | $89.97 | $3.61 | 8.29M | 2.55B |
Merck & Co. Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 235,116,337 | 212,235,768 | 169,355,061 | 174,601,686 |
| Revenue | 45,970,000 | 42,294,000 | 40,122,000 | 39,807,000 |
| EBITDA | 15,557,000 | 13,649,000 | 11,566,000 | 10,495,000 |
| Net Income | 9,314,000 | 6,220,000 | 2,394,000 | 3,920,000 |
| Total Assets | 83,331,000 | 82,637,000 | 87,872,000 | 95,377,000 |
| Total Debt | 26,088,000 | 25,114,000 | 24,410,000 | 24,842,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Merck & Co. Competitors (90)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Active Biotech | Corporation | Lund, Sweden | 00 | 000.00 | 000000000 | 000.00 |
| 0000000000 0000000 | Corporation | San Francisco, CA | 000 | 000000&0 | ||
| 000000000(00000000 | Formerly VC-backed | New York, NY | 000 | 00000 | 000000 - 000 | 00000 |
| 000 000000 00000 | Private Debt Financed | Bresso, Italy | 0000 | 000.00 | 000000000 | 000.00 |
| 000000 | Formerly VC-backed | Lyon, France | 000 | 000.00 | 00000000 | 000.00 |
Merck & Co. Investments & Acquisitions (56)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 16-Jan-2020 | 000000000000000000 | 00.00 | Pharmaceuticals | 00000 0000000000 00.0 |
| 000000 0000000000 | 18-Sep-2019 | 00000 00000 00 | 000.00 | Biotechnology | |
| 0000000 0000000000 | 11-Jul-2019 | 000000000000000000 | 00.000 | Pharmaceuticals | 0000000 0000000 00 |
| 00000 000000000000 | 01-Jun-2019 | 000000000000000000 | 00000 | Biotechnology | 0000 00 00.0 |
| Immune Design | 02-Apr-2019 | Merger/Acquisition | 00000 | Biotechnology | 00000 0000000000 00.0 |
Merck & Co. Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 | 25-Jul-2018 | 00000 00000 00 | 00000 | Completed |
|
| 0000000 | 07-Jan-2016 | 00000 00000 00 | 000.00 | Completed |
|
| 0000000 00000000 | 06-Jan-2016 | 000000000 | 0000 | Completed |
|
| 0000000 0000000000 | 17-Nov-2014 | 00000 | Completed |
|
|
| eCardio Diagnostics | 09-Sep-2014 | Merger/Acquisition | Completed |
|
Merck & Co. Subsidiaries (19)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Tilos Therapeutics | Biotechnology | Lexington, MA | 2016 |
| 00000000 | Biotechnology | Munich, Germany | 0000 |
| 0000000 0000000000 | Pharmaceuticals | Dallas, TX | 0000 |
| 00000 000000 00000 | Corporate Venture Capital | Kenilworth, NJ | 0000 |
| 00000 000000 | Other Pharmaceuticals and Biotechnology | Edinburgh, United Kingdom | 0000 |
Merck & Co. Executive Team (68)
39 Former Executives
You’re viewing 5 of 68 executives. Get the full list »Merck & Co. Board Members (20)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000 000000 | Self | Board Member | 000 0000 | |
| 0000000 0000000 00 | Merck & Co. | Chief Executive Officer & Chairman | 000 0000 | |
| 000000 0000 | Self | Board Member | 000 0000 | |
| 0000 000 | Merck & Co. | Board Member | 000 0000 | |
| 000000 00000 | Self | Board Member | 000 0000 |
7 Former Board Members
You’re viewing 5 of 20 board members. Get the full list »